Tuberculosis (TB) Targeted Testing & Treatment of Latent TB Infection (LTBI)
This laminated information card provides information on the revised guidelines for targeted testing and treatment for LTBI.
This laminated information card provides information on the revised guidelines for targeted testing and treatment for LTBI.
This fact sheet provides information on the BCG vaccine and its effects on TB skin tests. Contact information for Toronto TB clincs is also given.
This electronic resource provides an interface for entering patient data to create a drug-o-gram. It includes a user's guide with instructions and teaching points. To download the program, Windows 2000/XP and Microsoft Access are required.
This fact sheet explains who should and who should not get vaccinated against TB. It also explains how to interpret tuberculin skin test results in people who have received the vaccination and the treatment for LTBI in BCG-vaccinated persons.
This fact sheet provides information on tuberculin skin testing. It explains how to interpret tuberculin skin test (TST) results, including special considerations.
This fact sheet details the three levels of TB infection control in health-care settings, considerations for selection of respirators, and implementing a respiratory protection program.
This fact sheet gives an overview of TB infection-control measures and explains how to determine the infectiousness of TB patients.
This fact sheet details the difference between Latent TB Infection (LTBI) and Active TB Disease. A general description of TB is also given.
This fact sheet covers when you should suspect Tuberculosis (TB). The fact sheet also details how to evaluate a person suspected of having TB disease.
This fact sheet provides an overview of the treatment of drug-susceptible tuberculosis disease in persons not infected with HIV including the recommended drug regimens, case management, and follow-up evaluations.